Mankind Pharma India records 62% surge in Q4 FY24 PAT at Rs 477cr

Mankind Pharma India, the nation’s fourth-largest pharmaceutical company, announced robust financial results for the fourth quarter and the fiscal year ending March 31, 2024. Demonstrating ... Read More